These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20618788)

  • 1. Comparative assessment for medications and devices: apples and oranges?
    Ramsey S
    Value Health; 2010 Jun; 13 Suppl 1():S12-4. PubMed ID: 20618788
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflating the approval process and clinical research with pharmacoeconomic evaluation.
    Somberg JC
    Am J Ther; 2013 Jan; 20(1):1. PubMed ID: 23299228
    [No Abstract]   [Full Text] [Related]  

  • 3. Identifying and eliminating the roadblocks to comparative-effectiveness research.
    Martin DF; Maguire MG; Fine SL
    N Engl J Med; 2010 Jul; 363(2):105-7. PubMed ID: 20519677
    [No Abstract]   [Full Text] [Related]  

  • 4. Missing evidence.
    Hayes WS
    MLO Med Lab Obs; 2008 Oct; 40(10):68. PubMed ID: 18988559
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise and future of comparative effectiveness research.
    Clancy CM
    J Nurs Care Qual; 2010; 25(1):1-4. PubMed ID: 20010250
    [No Abstract]   [Full Text] [Related]  

  • 6. Building comparative efficacy and tolerability into the FDA approval process.
    O'Connor AB
    JAMA; 2010 Mar; 303(10):979-80. PubMed ID: 20215612
    [No Abstract]   [Full Text] [Related]  

  • 7. The relevance of international studies to informed pharmacoeconomics and health policy decisions.
    Lyles A
    Clin Ther; 2010 Jan; 32(1):106-7. PubMed ID: 20171416
    [No Abstract]   [Full Text] [Related]  

  • 8. How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.
    Selby J; Slutsky J
    J Comp Eff Res; 2014 Nov; 3(6):565-6. PubMed ID: 25494560
    [No Abstract]   [Full Text] [Related]  

  • 9. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments.
    Dormer L; Greenfield S
    J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558
    [No Abstract]   [Full Text] [Related]  

  • 10. European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287.
    Flavell DJ; Flavell SU; Sullivan R
    Lancet; 2003 Oct; 362(9393):1415. PubMed ID: 14585646
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
    Hecker SJ; Preston C; Foote M
    Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatology clinical trials and drug development.
    Ehrenberger HE; Joshi TG
    Dermatol Nurs; 2003 Oct; 15(5):428-34. PubMed ID: 14619320
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effectiveness.
    Aston G
    Trustee; 2010 Jan; 63(1):13-4, 19-21. PubMed ID: 20143663
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical devices on trial, Part I.
    Wright D
    Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 17. Charting a path from comparative effectiveness funding to improved patient-centered health care.
    Conway PH; Clancy C
    JAMA; 2010 Mar; 303(10):985-6. PubMed ID: 20215615
    [No Abstract]   [Full Text] [Related]  

  • 18. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
    Stein J
    N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness research: does the emperor have clothes?
    Coulter ID
    Altern Ther Health Med; 2011; 17(2):8-15. PubMed ID: 21717820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Recovery and Reinvestment Act-comparative effectiveness research infrastructure investments: emerging data resources, tools and publications.
    Segal C; Holve E
    J Comp Eff Res; 2014 Nov; 3(6):647-55. PubMed ID: 25494571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.